
Biotech investor/trader - Host of Breaking Biotech https://teapaw.org/t.co/P6wtEkED8z [email protected]
San Diego, CA
Joined September 2017
- Tweets1.3K
- Following464
- Followers2.2K
- Likes3.1K
Breaking Biotech retweeted
Check out Breaking Biotech’s recent interview with our CEO, John Bencich and @MatthewLepoire to learn more about the ongoing development of cytisinicline for #smokingcessation. Click here to view the full interview: youtube.com/watch?v=NEAzxbP-… #quitsmoking
Breaking Biotech retweeted
*FDA DENIES CITIZEN PETITION ON CASSAVA DRUG
$SAVA
Breaking Biotech retweeted
CymaBay’s CEO Sujal Shah was recently a guest on the Breaking Biotech podcast with @MatthewLepoire where he shared details on Primary Biliary Cholangitis (PBC) and seladelpar. Watch the full conversation here: youtube.com/watch?v=G4uEDGnN…
#PBC #Podcast #RareDisease #LiverDisease
Breaking Biotech retweeted
$LGVN short interest is $8M
381.61K shares shorted
14.20 % SI% of Float
12.43 % S3 SI% Float
113.57 % fee
Shares shorted down -31K shs, worth $621K, -7.44 %, over the last week.
Shorts down -$6M in 2021 mark-to-market losses;
including +$244K on today's -3.36 % move.
Breaking Biotech retweeted
#NEWS: Today w/ @Pfizer, we announced that updated safety & efficacy data from our jointly developed investigational novel PROTAC® protein degrader will be presented in a poster-discussion session at @SABCSSanAntonio. Learn more: https://teapaw.org/t.co/Naw5AqiAlv #SABCS21
Breaking Biotech retweeted
LIFESCI $ALXO (OUTPERFORM,$87.00 PT): SITC update: Mixed outcome as gastric update shines and head and neck data disappoint
Breaking Biotech retweeted
Check out the latest #podcast episode of #BreakingBiotech where our President & CEO, @JohnGHouston, sat down with @MatthewLepoire to discuss the exciting progress of our #PROTAC technology. ⬇️
102 - Arvinas' PIONEERING PROTAC Tech to Enhance Cancer Outcomes | Interview with CEO John Houston $ARVN @ArvinasInc @JohnGHouston youtu.be/nmbD4HsraBE
Breaking Biotech retweeted
100 - AbSci Leverages AI to Become the GOOGLE of Drug Discovery! Interview with CEO Sean McClain $ABSC youtu.be/mcx3GeQWlIE
Breaking Biotech retweeted
4D Molecular Therapeutics Announces Late-Breaking Presentation of 4D-125 Clinical Data at the Upcoming ASRS Annual Meeting - 4D Molecular Therapeutics $FDMT moment of truth! ir.4dmoleculartherapeutics.c…
Breaking Biotech retweeted
U.S. FDA CALLS FOR FEDERAL INVESTIGATION INTO ITS CONTROVERSIAL ALZHEIMER’S DRUG APPROVAL - STAT NEWS
$BIIB
Breaking Biotech retweeted
094 - Checkpoint Therapeutics Targets MASSIVE Solid Tumor Market | Interview with CEO James Oliviero $CKPT $TGTX $FBIO youtu.be/q8_ZiAEcPYA
Breaking Biotech retweeted
$ALXO Oncology Announces New Data from ASPEN-01, the Phase 1b--- ORR of 72% Observed in Patients with >2L HER2 Positive Gastric or Gastroesophageal Junction Cancer
-- Estimated OS at 12 months of 76%
Conference Call on July 6th at 8:30 a.m. ET globenewswire.com/news-relea…
Breaking Biotech retweeted
092 - Biotech Bears CRUSHED with Biogen's Aduhelm Approval! CRIS/REPL Decline on Data Updates $BIIB $REPL $CRIS youtu.be/RM046q9B4Vo
Breaking Biotech retweeted
Interesting strategy to improve sales by $KPTI. Gets rid of Chief commercial officer position investors.karyopharm.com/202…
Breaking Biotech retweeted
$FDMT - preclinical NHP wet AMD data on May 12th - abstract notes "no evidence of chronic intraocular inflammation"






















